Mast Cell Activation Syndrome (MCAS): The Underdiagnosed Allergic-Autonomic Condition

3D illustration of a mast cell releasing its granules
In mast cell activation syndrome the mast cells are not increased in number but release their granules too easily
Infographic: a mast cell affecting skin, gut, heart, lungs and nerves
Mediators such as histamine, tryptase, leukotrienes and prostaglandins act on the skin, gut, heart and blood vessels, lungs and nervous system at once
Two serum tubes in a rack, a baseline sample and a flare sample
A serum tryptase rise of more than 20% above baseline plus 2 ng/mL during a flare is described as highly suggestive of mast cell activation

Mast cell activation syndrome (MCAS) is a condition in which mast cells — immune cells that mediate allergic responses — are not numerically increased (as they are in mastocytosis) but are inappropriately activated, releasing histamine, tryptase, leukotrienes, prostaglandins, and dozens of other mediators in response to triggers that should not provoke them. The result is a multi-system illness that affects skin, gastrointestinal tract, cardiovascular and respiratory systems, and nervous system. Mast cell activation syndrome is often triggered or unmasked by infections (including Epstein-Barr virus (EBV) and COVID-19), physical trauma, pregnancy, or hormonal transitions, and it clusters heavily with postural orthostatic tachycardia syndrome (POTS) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Deep-Dive Articles

Mast cell activation syndrome is a diagnosis where most patients end up managing themselves — the workup is slow, the specialists are few, and the day-to-day tradeoffs (what to eat, which antihistamines to stack, when to escalate) fall on you. The eight articles below cover the pieces in plain language: how to test for it, how to eat, how to medicate, how to prevent flares, and where the natural-medicine layer actually helps.

🗺️

Mediators & Symptom Map

Histamine, tryptase, prostaglandin D2, leukotrienes, heparin, chromogranin A — what each chemical mast cells release actually does in your body, and which symptoms point to which mediator. The key to targeted treatment.

Read the deep dive →
🧪

Mast Cell Activation Syndrome Testing Guide

Serum tryptase, 24-hour urine N-methylhistamine, prostaglandin D2, leukotriene E4, chromogranin A. When to draw during a flare, why most tests come back “normal” even when you’re clearly reacting, and what the Consensus-1 and Consensus-2 criteria require.

Read the deep dive →
🥗

Low-Histamine Diet

The complete food lists, DAO enzyme supplementation, histamine liberators (foods that don’t contain histamine but make your body release its own), fresh-is-best rules, leftovers as poison, and why this is a short-term tool, not a life sentence.

Read the deep dive →
💊

H1/H2 Blocker Stacks

Cetirizine, fexofenadine, loratadine, hydroxyzine, famotidine, ranitidine (gone), Xyzal, diphenhydramine — which antihistamines do what, morning vs. night dosing, the H1+H2 combo, and when to double up safely.

Read the deep dive →
🛡️

Cromolyn & Ketotifen Protocols

Second-line stabilizers for when antihistamines aren’t enough. Oral cromolyn sodium (Gastrocrom) dosing, compounded ketotifen, titration schedules, side-effect management, and how to find a compounding pharmacy.

Read the deep dive →
📓

Triggers & Flare Management

How to build a trigger diary that actually reveals your pattern, the most common culprits (heat, friction, stress, hormonal cycles, specific foods, exercise), and a step-by-step flare rescue plan before and during an episode.

Read the deep dive →
🧬

Hereditary α-Tryptasemia

A genetic duplication of the TPSAB1 gene that drives elevated baseline tryptase and mimics mast cell activation syndrome. Testing, what the diagnosis changes, and how it overlaps with Ehlers-Danlos syndrome (EDS) and postural orthostatic tachycardia syndrome.

Read the deep dive →
🌿

Natural Mast Cell Stabilizers

Quercetin, luteolin, vitamin C, nigella sativa, holy basil, PEA. Dosing, product-quality notes, and how they stack with prescription antihistamines. The evidence-based natural layer.

Read the deep dive →
🌙

Hormone Sensitivity & Menstrual Flares

Why estrogen triggers mast cells — cyclic flares, pregnancy, perimenopause.

Read the deep dive →

What Mast Cell Activation Syndrome Is

Mast cells normally release their granule contents only in response to specific allergen-IgE binding or genuine pathogen signals. In mast cell activation syndrome, they degranulate repeatedly in response to non-immunologic triggers — heat, cold, stress, friction, certain foods, certain medications, exercise, and even emotional stimuli. The downstream effects cascade across systems because mast cells sit at tissue interfaces throughout the body — skin, gut mucosa, blood-vessel walls, respiratory tract, and perivascular nervous tissue.

Multi-System Symptoms

Symptoms typically span at least two organ systems and fluctuate:

Diagnostic Criteria

Consensus criteria require all three:

  1. Episodic symptoms consistent with mast-cell mediator release affecting at least two organ systems.
  2. Objective evidence of mast-cell mediator release — elevated serum tryptase measured during or within 4 hours of a symptomatic episode, or elevated 24-hour urinary n-methyl-histamine, prostaglandin D2 metabolite, or leukotriene E4.
  3. Response to mast-cell-directed therapy.

In practice, mediator measurement is often falsely negative because labs are typically drawn between flares. The clinical picture and therapeutic response are often the most meaningful signals.

Common Triggers

Workup

Treatment — The Stepped Approach

  1. H1 antihistamines — cetirizine, loratadine, fexofenadine at standard doses, titrating upward as needed (sometimes 2–4x standard).
  2. H2 antihistamines — famotidine, added to H1.
  3. Mast-cell stabilizers — cromolyn sodium oral solution before meals, ketotifen.
  4. Leukotriene inhibitors — montelukast, zafirlukast.
  5. Quercetin as a natural mast-cell stabilizer (see Quercetin).
  6. Vitamin C — aids quercetin recycling and has some antihistamine effect.
  7. Aspirin at low dose for flushing (only with tolerance confirmed).
  8. Omalizumab for severe refractory cases.
  9. Emergency epinephrine for patients with history of anaphylaxis.

Low-Histamine Diet

Short-term (2–4 weeks) elimination of high-histamine and histamine-releasing foods often reveals how large a contribution diet is making. Avoid: aged cheeses, cured meats, fermented foods (kimchi, sauerkraut, kombucha), alcohol, vinegar-containing products, tomatoes, spinach, eggplant, citrus, avocado, nuts, shellfish, and leftovers more than 24 hours old. Favor freshly prepared, fresh meats, non-citrus fruits, rice, gluten-free grains. Low-histamine diet is a diagnostic and symptom-management tool, not a lifelong sentence — reintroduction under control is part of the protocol.

Overlap with Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and Ehlers-Danlos Syndrome

Mast cell activation syndrome, postural orthostatic tachycardia syndrome, and Ehlers-Danlos syndrome / hypermobility spectrum disorder form the classic “triad.” myalgic encephalomyelitis/chronic fatigue syndrome sits adjacent. Screening for the other members of the cluster is often done, although a 2025 systematic review found no study using strict diagnostic criteria that confirms a link between mast cell activation disorders and POTS or EDS. Proposed shared mechanisms include mast-cell–autonomic interactions in perivascular tissue, connective-tissue fragility affecting autonomic ganglia, and shared post-infectious pathophysiology.

Table of Contents

  1. Deep-Dive Articles
  2. What Mast Cell Activation Syndrome Is
  3. Multi-System Symptoms
  4. Diagnostic Criteria
  5. Common Triggers
  6. Workup
  7. Treatment — The Stepped Approach
  8. Low-Histamine Diet
  9. Overlap with Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and Ehlers-Danlos Syndrome
  10. Key Research Papers
  11. Connections
  12. Featured Videos

Back to Table of Contents

Key Research Papers

  1. Valent P, Akin C, Arock M, et al. (2012). Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. International Archives of Allergy and Immunology — PubMed PMID: 22041891
  2. Akin C, Valent P, Metcalfe DD (2010). Mast cell activation syndrome: Proposed diagnostic criteria. The Journal of Allergy and Clinical Immunology — PubMed PMID: 21035176
  3. Weiler CR, Austen KF, Akin C, et al. (2019). AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management. The Journal of Allergy and Clinical Immunology — PubMed PMID: 31476322
  4. Valent P, Bonadonna P, Hartmann K, et al. (2019). Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome. International Archives of Allergy and Immunology — PubMed PMID: 31256161
  5. Lyons JJ, Yu X, Hughes JD, et al. (2016). Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nature Genetics — PubMed PMID: 27749843
  6. Castells M, Butterfield J (2019). Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management. The Journal of Allergy and Clinical Immunology. In Practice — PubMed PMID: 30961835
  7. Nurmatov UB, Rhatigan E, Simons FE, et al. (2015). H1-antihistamines for primary mast cell activation syndromes: a systematic review. Allergy — PubMed PMID: 26095756
  8. Farley M, Estrada-Mendizabal RJ, Gansert EA, et al. (2025). Prevalence of mast cell activation disorders and hereditary alpha tryptasemia among patients with postural orthostatic tachycardia syndrome and Ehlers-Danlos syndrome: A systematic review. Annals of Allergy, Asthma & Immunology — PubMed PMID: 40185471

PubMed Topic Searches

Curated PubMed topic searches on Mast Cell Activation Syndrome (MCAS). Each link opens a live PubMed query so the result set stays current as new studies are indexed.

  1. PubMed: Topic search: Mast cell activation syndrome review
  2. PubMed: Topic search: MCAS diagnostic criteria
  3. PubMed: Topic search: Tryptase MCAS
  4. PubMed: Topic search: H1 H2 antihistamines MCAS
  5. PubMed: Topic search: Cromolyn sodium MCAS
  6. PubMed: Topic search: Ketotifen mast cell
  7. PubMed: Topic search: Hereditary alpha tryptasemia
  8. PubMed: Topic search: MCAS hEDS POTS overlap
  9. PubMed: Topic search: Mastocytosis review
  10. PubMed: Topic search: Omalizumab mast cell
  11. PubMed: Topic search: Low histamine diet
  12. PubMed: Topic search: Idiopathic MCAS clinical

Back to Table of Contents

Connections

Back to Table of Contents

mast cell activation syndrome — scientific infographic poster